Creating a diagnostic test to subtype lung cancer
Development of a lung cancer subtyping diagnostic
This study is working on a new test that helps doctors figure out the specific type of lung cancer you might have, so they can choose the best treatment for you and avoid unnecessary tests.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Orbit Genomics, INC. NIH-funded |
| Lab location | 1 site (Boulder, United States) |
| Project ID | NIH-11007304 on NIH RePORTER |
What this research studies
This research aims to develop a highly sensitive and specific diagnostic test that can accurately subtype lung cancer. By distinguishing between different subtypes of lung cancer, which vary in their pathology and treatment responses, the test will help doctors select the most effective therapies for patients. The approach involves enhancing an existing diagnostic tool that identifies benign versus malignant pulmonary nodules, thereby improving overall diagnostic accuracy and reducing unnecessary procedures. The research utilizes advanced algorithms and genomic data to refine the diagnostic process.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with lung cancer or those with indeterminate pulmonary nodules requiring further evaluation.
Not a fit: Patients with lung cancer subtypes that are not addressed by this diagnostic test may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could significantly improve lung cancer treatment outcomes by ensuring patients receive the most appropriate therapies based on their cancer subtype.
How similar studies have performed: Previous research has shown promise in developing diagnostic tests for cancer subtyping, indicating that this approach could lead to significant advancements in patient care.
Where this research is happening
Boulder, United States
- Orbit Genomics, INC. — Boulder, United States (Active)
Researchers
- Principal investigator: Garner, Harold R — Orbit Genomics, INC.
- Study coordinator: Garner, Harold R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.